REMICADE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 115 adverse event reports in the FDA FAERS database where REMICADE was used for Psoriasis.
Most Reported Side Effects for REMICADE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Infusion related reaction | 313 | 9.8% | 5 | 79 |
| Crohn's disease | 193 | 6.0% | 2 | 143 |
| Drug ineffective | 157 | 4.9% | 4 | 67 |
| Dyspnoea | 141 | 4.4% | 2 | 38 |
| Exposure during pregnancy | 96 | 3.0% | 0 | 19 |
| Arthralgia | 95 | 3.0% | 1 | 33 |
| Nausea | 85 | 2.7% | 1 | 29 |
| Pain | 84 | 2.6% | 0 | 33 |
| Vomiting | 81 | 2.5% | 0 | 45 |
| Malaise | 80 | 2.5% | 3 | 38 |
| Pyrexia | 77 | 2.4% | 5 | 54 |
| Off label use | 75 | 2.4% | 6 | 29 |
| Diarrhoea | 72 | 2.3% | 1 | 40 |
| Fistula | 71 | 2.2% | 1 | 19 |
| Abdominal pain | 70 | 2.2% | 1 | 42 |
Other Indications for REMICADE
Crohn's disease (1,383)
Rheumatoid arthritis (523)
Colitis ulcerative (433)
Product used for unknown indication (240)
Ankylosing spondylitis (199)
Psoriatic arthropathy (168)
Inflammatory bowel disease (101)
Colitis (29)
Arthritis (21)
Hidradenitis (11)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)